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ABSTRACT
The quality of evidence that psychological interventions are 
effective in improving glycemic control in adults with type 
2 diabetes (T2D) is weak.
We conducted a systematic review and meta- analysis 
of psychological interventions in T2D to assess whether 
their effectiveness in improving glycemic levels has 
improved over the past 30 years. We applied the protocol 
of a systematic review and aggregate meta- analysis 
conducted to January 2003. We added network meta- 
analysis (NMA) to compare intervention and control group 
type against usual care. MEDLINE, Cumulative Index to 
Nursing and Allied Health Literature, PsycINFO, EMBASE, 
Cochrane Controlled Trials Database, Web of Science, and 
Dissertation Abstracts International were searched from 
January 2003 to July 2018. Only randomized controlled 
trials (RCT) of psychological interventions for adults with 
T2D reported in any language were included. The primary 
outcome was change in glycemic control (glycated 
hemoglobin (HbA1c) in mmol/mol). Data were extracted 
from study reports and authors were contacted for missing 
data.
94 RCTs were eligible for inclusion in the systematic 
review since the last review. In 70 RCTs (n=14 796 
participants) the pooled mean difference in HbA1c in 
those randomized to psychological intervention compared 
with control group was −0.19 (95% CI −0.25 to −0.12), 
equivalent to a reduction in HbA1c of 3.7 mmol/mol, 
with moderate heterogeneity across studies (I2=64.7%, 
p<0.001). NMA suggested the probability of intervention 
effectiveness is highest for self- help materials, cognitive–
behavioral therapy, and counseling, compared with usual 
care. Limitations of this study include that there is a 
possibility that some studies may have been missed if 
diabetes did not appear in the title or abstract.
The effectiveness of psychological interventions for 
adults with T2D have minimal clinical beneit in improving 
glycemic control.
PROSPERO registration number CRD42016033619.
InTROduCTIOn
In type 2 diabetes (T2D), management 
involves adopting multiple self- care tasks 
which include consuming lower energy 
dense diets, increasing physical activity, 
self- administration of oral and injectable 
therapies, self- monitoring of blood glucose 
levels, decision- making about dose of insulin, 
and attending education and annual review 
appointments.
Despite evidence- based guidelines,1 
at least a third of people with T2D do 
not achieve target glycated hemoglobin 
(HbA1c) levels.2 This is partly attributable 
to psychological factors that adversely affect 
self- management. These include depressive 
disorders,3 anxiety disorders,4 and diabetes- 
specific distress, such as fear of diabetes 
complications, hypoglycemia,5 insulin,6 
disordered eating,7 the burden of living 
with T2D and stigma.8 Psychological treat-
ments, such as cognitive–behavioral therapy 
(CBT) and counseling, including motiva-
tional interviewing, are offered with the aim 
of improving self- management. In 2003, we 
conducted a systematic review and meta- 
analysis of randomized controlled trials 
(RCTs) testing the effectiveness of psycho-
logical interventions in improving glycemic 
control in T2D. We found that there was a 
small but clinically significant reduction in 
HbA1c by 8 mmol/mol.9 At that time, there 
were only 12 studies with a pooled sample 
of 522 participants, and most were published 
before the Consolidated Standards of 
Reporting Trials (CONSORT)10 and were of 
low methodological quality. Since then guid-
ance for conducting and reporting complex 
interventions has been published and widely 
disseminated, and there has been an explo-
sion in the number of RCTs. The aim was 
to conduct a systematic review and meta- 
analysis to assess the effectiveness of psycho-
logical treatments as compared with control 
conditions in improving glycemic control in 
adults with T2D and whether the strength 
for the association was improving over time.
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METhOdS
We repeated the original protocol for the systematic 
review and aggregate meta- analysis for the primary 
outcome, the change in HbA1c.9 We added network 
meta- analysis (NMA) to enable us to compare all inter-
vention arms and attention control groups with usual 
care and expanded the data extraction to include further 
details about the intervention that allow for potential 
replication; the protocol is available at https://www. jour-
nalslibrary. nihr. ac. uk/ programmes/ hta/ 1421310#/.11 12 
The Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses (PRISMA) statement13 and relevant 
extensions were followed.
data sources and searches
MEDLINE (OVID), Cumulative Index to Nursing and 
Allied Health Literature, PsycINFO, EMBASE (OVID), 
Cochrane Controlled Trials Database, Web of Science, 
and Dissertation Abstracts International were searched 
from 1 January 2003 to 1 July 2018. (Our earlier review 
searched literature from inception of electronic data-
bases to January 2003.) Conference proceedings from 
Diabetes UK, American Diabetes Association, European 
Association for the Study of Diabetes, and International 
Diabetes Federation were searched for the past 5 years 
(from 2012 to 2018). We checked the US government 
trial registry ( ClinicalTrials. gov) and searched publica-
tion status for any ongoing RCTs. Finally, the reference 
lists of the included studies and other reviews were 
searched for additional studies, and leading experts and 
investigators of ongoing RCTs identified from clinical 
trials registers were contacted for additional information. 
Web of Science (formerly Web of Knowledge), launched 
in 2002, and  ClinicalTrials. gov became widely mandated 
from 2004 onwards, and Dissertation Abstracts Interna-
tional is a leading international repository since 2008; 
therefore, these data sources were additional sources to 
those specified in the original protocol.9
We used the Cochrane Collaboration’s optimum 
search strategy. The following terms were applied to 
search MEDLINE: ‘diabetes mellitus’, ‘psychological 
therapies’ and ‘mood disorders’, and ‘clinical trials’; 
these were adjusted for other databases (online supple-
mentary appendix 1, online supplementary table S1). We 
included additional keywords for some newer therapies, 
such as ‘Acceptance Commitment Therapy (ACT)’ and 
‘Mindfulness’.
Study selection
Studies eligible for inclusion were RCTs of a psycholog-
ical intervention as defined previously for adults (age 18 
years and older) with T2D. There was no language restric-
tion. Psychological interventions were categorized as 
supportive or counseling therapy, including motivational 
interviewing; CBT, including techniques commonly 
used in CBT, such as relaxation, cognitive restructuring, 
goal- setting, and problem- solving; and psychodynamic 
or interpersonal psychotherapy. We were mindful that 
newer therapies may have been developed and may not 
fall into these criteria. Studies which did not explicitly 
describe the intervention or techniques or which did 
not have face validity for these categories underwent 
consensus discussion by an academic liaison psychiatrist, 
health psychologist and nurse therapist trained in moti-
vational interviewing (KI, RU, and KW, respectively). If 
agreement could not be reached, the study was excluded. 
Comparators were defined as usual care, waiting list, 
attention control (matching the number of sessions as in 
the intervention arm) and diabetes education.
The main outcome was change in glycemic control 
using HbA1c (mmol/mol) between baseline and 
follow- up (closest to 12 months). HbA1c was an inclusion 
criterion for the review.
All titles and abstracts of identified articles from the 
search were screened by two independent reviewers (RU 
and KW) to determine if they met the inclusion criteria. 
Full- text articles were accessed, and inter- rater reliability 
was conducted to determine agreement for inclusion. If 
there was a disagreement at title and abstract screening, 
the study was included for full- text screening. Quasi- RCT, 
N- of-1 and any design other than RCT were excluded.
data extraction and quality assessment
Data were extracted independently by both reviewers 
(RU and KW). The data extraction form was managed 
in Microsoft Excel, piloted independently on five 
included studies and compared among reviewers before 
applying to the rest of the studies. Studies written in a 
language other than English were translated and data 
were extracted by a native speaker. If there were multiple 
publications, the main one reporting the baseline and 
follow- up closest to 12 months was included. When 
studies involved more than one psychological treatment, 
data from the most intensive psychological treatment 
were included for the aggregate meta- analysis. Inten-
sity was defined as the number and duration of sessions 
(hours) and the duration of therapy (months). Data 
from all allocations (including alternative intervention, 
eg, self- help materials and control treatments) were 
extracted for NMA. Missing data were requested from the 
authors. Any disagreements were discussed with a third 
reviewer (KI) until consensus was reached. We extracted 
data in a standardized format for country of origin and 
year. Data extracted on participant characteristics were 
summary estimates and included age, gender, ethnicity, 
glycemic control at baseline and at follow- up, dura-
tion of T2D, type of diabetes treatment, and duration 
of follow- up. When studies included type 1 and type 2 
diabetes, only data on T2D were extracted if the data had 
been stratified by type. The characteristics of all interven-
tions were coded as type, duration, number of sessions, 
mode of delivery (individual, group, family), therapist 
characteristics (profession), manualized treatment, and 
duration of follow- up. In line with developments in meth-
odology for complex interventions,11 we extracted infor-
mation on underpinning psychological theory and data 
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describing fidelity to the intervention and competency of 
the therapist.12
We changed the quality assessment from the original 
protocol to the Cochrane Risk of Bias tool as this had 
greater validity14 in determining high, low or unclear 
risk of bias (RoB),14 within and across studies. RoB was 
conducted independently (RU and KW) and disagree-
ments were resolved by a third reviewer (KI). A subgroup 
meta- analysis was conducted by RoB rating, and meta- 
regression compared effect sizes between RoB groups.
data synthesis and analysis
For the aggregate meta- analysis, the standardized mean 
difference (SMD), Cohen’s d, was calculated to determine 
change in HbA1c (mmol/mol) between baseline and 
12- month follow- up or closest to that data point. SMDs 
were pooled in random- effects meta- analysis. SMDs were 
converted to absolute HbA1c values by multiplying SMD 
by pooled SD of all studies included in the meta- analysis. 
Diagnostic analyses included investigations of the effect 
of removing individual studies; Egger’s publication bias; 
and funnel plots15 and the trim and fill procedure16 to 
determine potential for missing studies. Meta- regression 
was conducted if there were five or more studies with data 
that could be pooled.17 All meta- analyses were conducted 
using STATA V.14.
Non- protocol analyses were performed. For example 
meta- regressions were performed for the association 
between HbA1c and the primary outcome category; 
HbA1c primary outcome (vs HbA1c secondary outcome); 
comorbid depression inclusion criteria (vs no comorbid 
depression criteria); and suboptimal HbA1c inclusion 
criteria (vs no suboptimal HbA1c inclusion criteria). In 
addition, meta- regressions were performed to determine 
the interaction between depressive symptoms as an inclu-
sion criterion and whether HbA1c was the study’s primary 
or secondary outcome, and the interaction between 
studies with suboptimal HbA1c as an inclusion criterion 
and whether HbA1c was the study’s primary outcome.
To determine the potential for cohort effects, we 
linked the data from the original meta- analysis removing 
any duplicate studies.
For the NMA we analyzed direct and indirect effects of 
the treatment and control arms on the mean change in 
HbA1c.18 Indirect effects compared categories of inter-
vention (psychological interventions, alternative treat-
ments) or control groups (usual care, attention control, 
waiting list, diabetes education) within and across studies. 
We constructed network plots for direct comparisons. 
We conducted random- effects meta- analysis allowing for 
heterogeneity and inconsistency between the studies.19 20 
Inconsistency was assessed by comparing direct and indi-
rect effects of the contrast I- J and Wald tests. Hedges’ g 
formula was used to determine unbiased SMDs corrected 
for df for different categories of intervention with usual 
care as the control.21 Finally, we estimated potential ranks 
for each category using cumulative probability plots and 
surface under the cumulative ranking (SUCRA); the 
higher the SUCRA (closest to 1), the greater the proba-
bility of the intervention being effective.
RESulTS
Study selection
We identified 31 069 study citations from the literature 
search (figure 1). Once duplicates were removed, titles 
and abstracts of 23 080 citations were screened, from 
which 547 full texts were selected for further extraction. 
There was 94.5% agreement in identifying abstracts for 
full retrieval (Cohen’s kappa=0.95). We identified 94 
RCTs that met the inclusion criteria for the systematic 
review, and the reasons for exclusion of the other studies 
are shown in figure 1.
Study characteristics
The studies included in the systematic review are listed 
and the study and intervention characteristics are synthe-
sized in online supplementary table S2. There was a 
broad range of clinical settings and/or criteria, such as 
suboptimal glycemic control (n=28), specific duration 
of diabetes (n=19), age (n=41), body mass index (n=10) 
and depression (n=11). There were no RCTs adminis-
tering psychodynamic therapy, while 33 RCTs admin-
istered CBT or techniques that fall under its umbrella 
such as relaxation therapy or problem- solving, 60 RCTs 
delivered counseling, and 1 used interpersonal psycho-
therapy (IPT). In the control group, there were 60, 20, 10 
and 4 studies administering usual care, attention control, 
waiting list, and diabetes education, respectively. Most 
therapists were diabetes specialists (n=37) or psycholo-
gists (n=31), and others (n=26) defined as research assis-
tants (n=10), non- diabetes health professionals (n=11), 
lay people (n=3), or did not report their profession 
(n=2). Most interventions were delivered face to face 
(n=75), and mostly to individuals (n=54) and groups 
(n=37). The mean number of therapy sessions offered 
was 7.41 (SD 4.60), the mean duration of each session 
was 1.40 hours (SD 1.03), and the mean duration of 
therapy was 5.44 months (SD 6.54). Twenty- seven studies 
referred to an intervention manual, of which 7 provided 
a link to the manual and 24 studies provided a link to the 
study protocol.
RoB within studies
Of the studies included in the meta- analysis, few were 
assessed as high RoB (n=3). The majority of studies were 
either of low RoB (n=29) or unclear RoB (n=38) (online 
supplementary figure S1), and there was no association 
between these RoB categories and HbA1c (p=0.23).
Results of individual studies
Additional information regarding the case definition 
of studies included in the meta- analysis is summarized 
in online supplementary table S3. There were 70 RCTs 
with data to be pooled, giving a total sample of n=14 
796. In the random- effects meta- analysis, while there was 
a statistically significant reduction in HbA1c for those 
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Figure 1 Qualitative and quantitative PRISMA low chart for all type 2 diabetes studies. *Sixteen studies were papers which 
included a type 1 and type 2 diabetes population where separate analysis per diabetes type could not be obtained. In the 
remaining eight studies which were not included in the meta- analysis, not enough information for meta- analysis was reported 
in the paper and could not be provided by author when contacted. **Three studies had a type 1 and type 2 diabetes population 
where separate analysis per diabetes type was obtained. PRISMA, Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses; RCT, randomized controlled trial.
randomized to a psychological intervention compared 
with the control group (SMD −0.19, 95% CI −0.25 to 
−0.12, p<0.001), this was of weak clinical significance, 
representing an absolute reduction in HbA1c of 3.7 
mmol/mol (figure 2). Removal of individual studies had 
little impact on the overall effect size. There was moderate 
heterogeneity across studies (I2=64.7%, p<0.001) and 
evidence of publication bias toward positive findings via 
Egger’s test (p=0.002). No additional studies were consid-
ered missing using the trim and fill method.
Synthesis of results
There was no significant difference in effect size (p=0.12) 
between interventionist categories when subgroup anal-
yses were conducted for interventions delivered by 
psychology professionals (n=23, SMD=−0.30, 95% CI 
−0.46 to –0.14, p<0.001; reduction in HbA1c, 5 mmol/
mol), diabetes specialists (n=30, SMD=−0.18, 95% CI 
−0.25 to –0.10, p<0.001; reduction in HbA1c 3 mmol/
mol), and ‘other’ interventionists (n=16, SMD=−0.07, 
95% CI −0.21 to 0.06, p=0.29; reduction in HbA1c, 1 
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Figure 2 Forest plot for a random- effect meta- analysis of standardized mean difference in HbA1c comparing psychological 
intervention with control group for adults with type 2 diabetes. A+, depressive symptoms in inclusion criteria; A-, depressive 
symptoms not inclusion criteria; B+, suboptimal HbA1c in inclusion criteria (7.5%/58mmol/mol or more); B-, suboptimal HbA1c 
not inclusion criteria; C+, HbA1c is primary outcome; C-, HbA1c is secondary outcome. HbA1c, glycated hemoglobin; SMD, 
standardized mean difference.
mmol/mol). Heterogeneity was high and significant 
for psychology professionals (I2=72.6%, p<0.001) and 
moderate for diabetes specialists (I2=57.7%, p<0.001) and 
‘other’ interventionists (I2=58.2%, p=0.002). For diabetes 
specialist delivered studies, there was some evidence of 
publication bias (p=0.01), but no additional studies were 
identified as missing using the trim and fill method. For 
psychology professional and ‘other’ interventionist deliv-
ered studies, there was no evidence of publication bias 
(p=0.09 and p=0.69, respectively), and no additional 
studies were identified as missing using the trim and fill 
method.
There was no dose–response association with the 
number of sessions (b=−0.0063 (95% CI −0.0224 to 
0.0097), p=0.43) or duration of psychological interven-
tion (b=−0.06 (95% CI −0.18 to 0.07), p=0.36) or control 
group (b=−0.02 (95% CI −0.11 to 0.08), p=0.75).
Additional analyses, non-protocol
We conducted some additional non- protocol analyses. 
We categorized studies into four groups according to 
their primary outcome (online supplementary table S4): 
HbA1c (n=33), psychological (n=19; diabetes empower-
ment n=1, depressive symptoms n=10, diabetes distress 
n=4, self- efficacy n=2, stress n=2), self- management 
behaviors (n=13; physical activity n=6, medication adher-
ence n=5, diet adherence n=2), or biomedical (n=5; 
coronary heart disease risk n=1, weight n=3, body mass 
index n=1). There was no association between type of 
primary outcome and change in HbA1c (p=0.33). A 
meta- regression revealed no significant difference in 
effect size in HbA1c reduction between studies where 
HbA1c was a primary outcome (n=33) compared with 
studies where HbA1c was a secondary outcome (n=37) 
(p=0.21).
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Out of the 70 included studies, 16 had an inclusion 
criterion for depressive symptoms, that is, where partic-
ipants had T2D with comorbid depressive symptoms 
(figure 2). A meta- regression revealed no significant 
difference in effect size in HbA1c reduction between 
studies with comorbid depression inclusion criteria 
and studies where there were no comorbid depression 
inclusion criteria (p=0.80). For six of the studies with 
comorbid depressive symptom inclusion criteria, HbA1c 
was the primary outcome (online supplementary table 
S5). A meta- regression was conducted for the interaction 
between depressive symptoms as an inclusion criterion 
and whether HbA1c was the study’s primary or secondary 
outcome; there was no significant difference between 
the groups (p=0.63). Additionally, some of the comorbid 
depression studies included collaborative care interven-
tions, and as these could be considered distinct from 
other psychological interventions we conducted a sensi-
tivity analysis and there was no difference in overall effect 
size (SMD=−0.19, 95% CI −0.26 to −0.13).
More information regarding inclusion/exclusion 
criteria of studies included in the meta- analysis can be 
found in online supplementary table S6.
Eleven studies had an inclusion criterion for subop-
timal glycemic control (HbA1c 7.5%/58 mmol/mol 
or more) (figure 2). A meta- regression revealed no 
significant difference in effect size in HbA1c reduction 
between studies where suboptimal HbA1c was an inclu-
sion criterion (SMD=−0.15, 95% CI −0.28 to −0.01) and 
studies where suboptimal HbA1c was not an inclusion 
criterion (SMD=−0.19, 95% CI −0.27 to −0.12, p=0.62). 
For eight studies with suboptimal glycemic control as 
the inclusion criterion, HbA1c was the primary outcome 
(online supplementary table S7). A meta- regression 
was conducted to determine the interaction between 
studies with suboptimal HbA1c as an inclusion criterion 
and whether HbA1c was the study’s primary outcome, 
and there was no significant difference between groups 
(p=0.51).
RoB across studies
The RoB domain which was most difficult to assess (ie, 
coded as ‘unclear RoB’) was the ‘blinding of participants 
and personnel’ domain (online supplementary figure 
S2). ‘Selective reporting’ and ‘other bias’ RoB domains 
were mostly coded as low RoB, while ‘Random sequence 
generation,’ ‘allocation concealment’ and ‘incomplete 
outcome data’ showed high RoB across studies.
Additional analyses: cohort effect
To examine whether there was a cohort effect, we pooled 
the HbA1c data from 12 RCTs included in an earlier 
meta- analysis (from inception to January 2003) with 
the current review (January 2003–July 2018), totaling 
82 RCTs (n=15 306). We derived a similar effect size to 
the current review (SMD −0.20, 95% CI −0.26 to −0.14, 
p<0.001, equivalent to absolute change in HbA1c of −4 
mmol/mol). The effect size was not significantly different 
between the two meta- analyses (b=−0.13 (95% CI −0.38 to 
0.12), p=0.31).
Additional analyses: nMA
For the NMA there were data available from 70 studies, 
which included five categories of psychological interven-
tion and three control conditions. In total 146 treatment 
arms were analyzed (some studies had more than one 
intervention or control group), with a total sample size 
of 15 702 (online supplementary table S8). A network 
plot for all studies demonstrated that 13 out of a possible 
28 contrasts could be analyzed (online supplementary 
figure S3), although to reduce overestimation of treat-
ment effects we only analyzed contrasts with two or more 
studies. IPT and diabetes education (control) were only 
studied once and were thus removed from the NMA, 
including the control group for IPT, resulting in a total 
number of studies of 142 with a total sample size of 15 
573, allowing us to study 11 out of a possible 15 contrasts.
Therefore, direct and indirect effects between CBT, 
counseling, self- help materials (alternative intervention 
treatment), usual care, attention control and waiting list 
control were performed. Online supplementary table 
S9 shows that the estimated direct and indirect effects 
between interventions did not differ significantly, with 
only one exception (counseling vs self- help materials). 
The non- significant χ2 test for inconsistency (χ2(8) 8.33, 
p=0.402, I2=3.9%) supports the conclusion of model 
consistency.
Online supplementary table 10 shows the results of 
the consistency of NMA comparing all treatments (and 
controls) against usual care. Self- help materials (this was 
an additional treatment arm, used in four studies), CBT, 
and counseling showed a small to moderate treatment 
effect. Online supplementary table S11 presents the pair-
wise comparisons of all treatment effects.
The rankogram (figure 3) indicated that self- help 
materials had the highest probability of being the 
most successful intervention (58.1%), followed by CBT 
(22.4%) and counseling (18.8%), while waiting list 
control, attention control and usual care were less likely 
to be the best treatment (all ≤0.6%). However, an assess-
ment of mean rank and SUCRA suggests little differences 
between self- help materials, CBT and counseling (online 
supplementary table S12).
COnCluSIOnS
In this study 94 RCTs were included in the systematic 
review and 70 had HbA1c data which could be pooled. 
There was a statistically significant improvement in 
glycemic control, but this was of weak clinical significance. 
The absolute reduction in HbA1c of 3.7 mmol/mol is just 
less than the consensus minimal difference of 4 mmol/
mol to reduce the risk of microvascular and cardiovas-
cular disease.22 The NMA demonstrated that CBT and 
counseling interventions were effective compared with 
controls, but effect sizes were small. Self- help was offered 
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Figure 3 Rankogram for all treatments. The plot shows 
the surface under the cumulative ranking curves for all 
treatments for adults with type 2 diabetes. For example, 
usual care has a very low probability of being among the best 
treatments but a very high probability of being one of the 
worst. CBT, cognitive–behavioral therapy.
as an alternative treatment to CBT (n=1268) or coun-
seling (n=6105) in four studies and this was effective, but 
the total sample size was smaller (n=792). There was no 
difference in the change in glycemic control when inter-
ventions were delivered by mental health or non- mental 
health professionals. Most studies were conducted in 
North America and Europe.
The strengths of this systematic review were that it was 
protocolized, registered with PROSPERO (International 
Prospective Register of Systematic Reviews), conducted 
according to PRISMA guidelines, and not restricted to 
English- language publications. We used aggregate and 
network meta- analysis to optimize the analysis of the 
pooled data. As we used the same protocol, we were 
able to link current data with a previous meta- analysis to 
compare the effects of psychological interventions over 
30 years.
The limitations of this review are that by using an older 
protocol we may have missed some innovative studies, 
and clinical settings such as multimorbidity and digital 
interventions where diabetes may have not appeared in 
the title or abstract. We used outcome data closest to 
12- month follow- up as the majority of the included trials 
were of short duration. We did not review the content 
of the manuals as there was no systematic method to do 
so. We included collaborative care interventions under 
the CBT umbrella, and it could be argued that collabo-
rative care is a complex intervention which differs from 
other psychological interventions. However, when collab-
orative care studies23–25 were removed from our overall 
aggregate meta- analysis, there was no significant change 
in the results. While we were able to determine whether 
the effect sizes of the current and previous review were 
different, we were not able to determine if there were 
differences in effectiveness of psychological interven-
tions according to study population or type of therapy.
Our observation is that in the past 15 years there has 
been an almost 10- fold increase in the number of RCTs 
testing the effectiveness of psychological interventions 
to improve glycemic control as primary or secondary 
outcome, yet their effectiveness has decreased compared 
with pre- CONSORT studies. This needs discussion 
within the diabetes and mental health research and 
clinical community. Similar patterns of increasing 
research productivity yet decreasing effectiveness have 
been observed by others but have not until now been 
debated.26–28 One explanation is that despite guidance 
on the assessment for fidelity to the psychological inter-
vention,29 there is little evidence that this is conducted. 
Deviations in fidelity to a psychological intervention can 
lead to dilution of the ‘dose’ and underestimation of its 
effect. Another possible explanation is the lack of data 
on the level of proficiency or competency in the delivery 
of psychological treatments.29 A third explanation is 
whether the primary focus of the psychological treatment 
is targeting glycemic control or other aspects of diabetes 
self- management. Only a quarter of studies had links to 
additional materials or manuals that would give informa-
tion on the specific content of the intervention. Only a 
third of the studies were focused on glycemic control. 
A significant proportion focused on treating depressive 
symptoms or weight with the secondary outcome that this 
would improve glycemic control. We also noticed there 
was no difference in the effect on glycemic control by 
the profession of the therapist. One interpretation is that 
diabetes specialists bring diabetes knowledge which is 
likely to be an important prerequisite to a therapeutic 
alliance for a person with diabetes. On the other hand, 
the mental health profession brings psychotherapeutic 
skills which are also a prerequisite to building a thera-
peutic relationship. These skills may be more effective 
when combined. A fifth explanation is that the interven-
tion in the control was of high standard, usual care for 
diabetes has improved, and the HbA1c national average 
has dropped in some countries.2 30 Last but not least, 
as the methodological quality has improved with only 
a handful of RCTs assessed to be of high RoB, another 
explanation is that collectively these types of interven-
tions, namely CBT and counseling, are not indicated 
in T2D. The average number of sessions was 7 and the 
average duration of the intervention was approximately 5 
months. T2D is a progressive condition and if a person is 
not able to make the self- management changes alone or 
with standard support, it is possible that they are unlikely 
to do so with a brief relatively inexpensive psychological 
intervention.
This review highlights a need for a balanced debate. 
On the one hand there is a clear policy agenda for 
integrating physical and mental health in diabetes, but 
there need to be psychological interventions that are 
effective in improving blood glucose, as ineffective inter-
ventions could do more harm and cost health systems 
more. National and international research strategy led 
by funding organizations need to invest in innovations in 
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psychological treatments, rather than replicating existing 
psychological models that are repeatedly delivering very 
small effect sizes. For instance, there were no studies 
that used psychodynamic models or addressed the high 
levels of disordered or addictive eating patterns, stigma 
of diabetes, or habit formation.31
In summary, brief psychological interventions in T2D 
have limited clinical effectiveness in improving glycemic 
control.
Author afiliations
1Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College 
London, London, UK
2Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 
London, UK
3Department of Biostatistics, King’s College London, London, UK
4School of Health and Related Research, Health Economics and Decision Science, 
University of Shefield, Shefield, UK
5Department of Oncology & Metabolism, University of Shefield, Shefield, UK
Acknowledgements We would like to thank the following individuals for 
translation of non- English- language publications: Sara Correia Simao and Rayane 
Chami.
Contributors KW and KI conceived the study, and DS, SRH and AB made 
substantial contributions to the study design. RU conducted the literature search. 
KW and RU acquired the study data. RU, DS and DP conducted the data analysis. 
KW, RU, DS and DP interpreted the data. RU and DS produced the igures. KW 
wrote the manuscript, with substantial contributions, critical review and revision 
of the manuscript from RU, DS and KI. DP, SRH and AB provided critical review and 
revision of the manuscript. All authors provided inal approval for the publication 
of the manuscript. All authors agreed to be accountable for all aspects of the work 
in ensuring that questions related to the accuracy or integrity of the work are 
appropriately investigated and resolved.
Funding This work was supported by the National Institute for Health Research 
(NIHR) Health Technology Assessment (HTA) Evidence Synthesis Programme, 
UK (grant number 12/213/10). The views expressed are those of the authors 
and not necessarily those of the NHS, the NIHR or the Department of Health and 
Social Care. The funders had no role in study design, data collection, analysis, 
interpretation, or writing of the report.
Competing interests KW has served as a consultant or speaker for MSD 
and Valotech. SRH has served as a consultant for Lilly, Novo Nordisk, Takeda, 
Boehringer Ingelheim, MannKind, Sanoi, Zealand Pharma and UN- EEG. He 
is a recipient of an award from the NIHR to evaluate a complex intervention, 
DAFNEplus, designed to improve glycemic control in adults with type 1 diabetes. KI 
has received honorarium for educational lectures for Janssen, Sanoi, Eli Lilly and 
Novo Nordisk.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Data are available upon reasonable request. All data 
relevant to the study are included in the article or uploaded as supplementary 
information.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCId id
Kirsty Winkley http:// orcid. org/ 0000- 0002- 1725- 6040
REFERENCES
 1 NICE. Type 2 diabetes in adults: management, 2017. 
Available: https://www. nice. org. uk/ guidance/ ng28/ chapter/ 1- 
Recommendations# hba1c- measurement- and- targets [Accessed 26 
June 2019].
 2 NDA. National diabetes audit, 2016-17, 2018Retrieved from. 
Available: https:// iles. digital. nhs. uk/ pdf/ s/ k/ national_ diabetes_ audit_ 
2016- 17_ report_ 1__ care_ processes_ and_ treatment_ targets. pdf 
[Accessed 24 May 2019].
 3 Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of 
comorbid depression in adults with diabetes: a meta- analysis. 
Diabetes Care 2001;24:1069–78.
 4 Grigsby AB, Anderson RJ, Freedland KE, et al. Prevalence of anxiety 
in adults with diabetes: a systematic review. J Psychosom Res 
2002;53:1053–60.
 5 Wild D, von Maltzahn R, Brohan E, et al. A critical review of the 
literature on fear of hypoglycemia in diabetes: implications for 
diabetes management and patient education. Patient Educ Couns 
2007;68:10–15.
 6 Brod M, Kongsø JH, Lessard S, et al. Psychological insulin 
resistance: patient beliefs and implications for diabetes 
management. Qual Life Res 2009;18:23.
 7 Allison KC, Crow SJ, Reeves RR, et al. Binge eating disorder and 
night eating syndrome in adults with type 2 diabetes. Obesity 
2007;15:1287–93.
 8 Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial 
distress in diabetes: development of the diabetes distress scale. 
Diabetes Care 2005;28:626–31.
 9 Ismail K, Winkley K, Rabe- Hesketh S. Systematic review and 
meta- analysis of randomised controlled trials of psychological 
interventions to improve glycaemic control in patients with type 2 
diabetes. Lancet 2004;363:1589–97.
 10 Moher D, Schulz KF, Altman DG, et al. The CONSORT statement: 
revised recommendations for improving the quality of reports of 
parallel- group randomised trials. Elsevier, 2001.
 11 Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of 
interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014;348:g1687.
 12 NIHR. A systematic review of psychological interventions to improve 
motivation for self- management in people with type 1 and type 2 
diabetes, 2019Retrieved from. Available: https://www. journalslibrary. 
nihr. ac. uk/ programmes/ hta/ 1421310#/ [Accessed 23 May 2019].
 13 Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for 
systematic reviews and meta- analyses: the PRISMA statement. Ann 
Intern Med 2009;151:264–9.
 14 Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane 
collaboration's tool for assessing risk of bias in randomised trials. 
BMJ 2011;343:d5928.
 15 Egger M, Davey Smith G, Schneider M, et al. Bias in meta- analysis 
detected by a simple, graphical test. BMJ 1997;315:629–34.
 16 Duval S. Tweedie R. A nonparametric “trim and ill” method of 
accounting for publication bias in meta- analysis. J Am Stat Assoc 
2000;95:89–98.
 17 Borenstein LH M, Higgins JPT, Rothstein HR. Introduction to meta- 
analysis, 2011.
 18 Riley RD, Jackson D, Salanti G, et al. Multivariate and network meta- 
analysis of multiple outcomes and multiple treatments: rationale, 
concepts, and examples. BMJ 2017;358:j3932.
 19 White IR, Barrett JK, Jackson D, et al. Consistency and 
inconsistency in network meta- analysis: model estimation using 
multivariate meta- regression. Res Synth Methods 2012;3:111–25.
 20 Higgins JPT, Jackson D, Barrett JK, et al. Consistency and 
inconsistency in network meta- analysis: concepts and models for 
multi- arm studies. Res Synth Methods 2012;3:98–110.
 21 White IR, Thomas J. Standardized mean differences in individually- 
randomized and cluster- randomized trials, with applications to meta- 
analysis. Clin Trials 2005;2:141–51.
 22 Baxter M, Hudson R, Mahon J, et al. Estimating the impact of better 
management of glycaemic control in adults with type 1 and type 2 
diabetes on the number of clinical complications and the associated 
inancial beneit. Diabet Med 2016;33:1575–81.
 23 Chwastiak LA, Luongo M, Russo J, et al. Use of a mental 
health center collaborative care team to improve diabetes 
care and outcomes for patients with psychosis. Psychiatr Serv 
2018;69:349–52.
 24 Ell K, Katon W, Xie B, et al. One- Year postcollaborative depression 
care trial outcomes among predominantly Hispanic diabetes safety 
net patients. Gen Hosp Psychiatry 2011;33:436–42.
 25 Williams JW, Katon W, Lin EHB, et al. The effectiveness of 
depression care management on diabetes- related outcomes in older 
patients. Ann Intern Med 2004;140:1015–24.
 26 Ekong G, Kavookjian J. Motivational interviewing and outcomes in 
adults with type 2 diabetes: a systematic review. Patient Educ Couns 
2016;99:944–52.
 o
n
 April 20, 2020 by guest. Protected by copyright.
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2019-001150 on 8 April 2020. Downloaded from 
9BMJ Open Diab Res Care 2020;8:e001150. doi:10.1136/bmjdrc-2019-001150
Psychosocial research
 27 Pillay J, Armstrong MJ, Butalia S, et al. Behavioral programs for type 
2 diabetes mellitus: a systematic review and network meta- analysis. 
Ann Intern Med 2015;163:848–60.
 28 Xie J, Deng W. Psychosocial intervention for patients with type 
2 diabetes mellitus and comorbid depression: a meta- analysis 
of randomized controlled trials. Neuropsychiatr Dis Treat 
2017;13:2681–90.
 29 Gearing RE, El- Bassel N, Ghesquiere A, et al. Major ingredients 
of idelity: a review and scientiic guide to improving quality 
of intervention research implementation. Clin Psychol Rev 
2011;31:79–88.
 30 Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in U.S. 
diabetes care, 1999-2010. N Engl J Med 2013;368:1613–24.
 31 Gardner B, Rebar AL. Habit formation and behavior change. Oxford 
Research Encyclopedia of Psychology, 2019.
 o
n
 April 20, 2020 by guest. Protected by copyright.
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2019-001150 on 8 April 2020. Downloaded from 
